Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • Log out
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • Log out
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Secretion of E,E-Farnesol and Biofilm Formation in Eight Different Candida Species

K. Weber, R. Sohr, B. Schulz, M. Fleischhacker, M. Ruhnke
K. Weber
Division of Oncology and Hematology, Department of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Sohr
Institute of Pharmacology, Charité—Universitätsmedizin Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Schulz
Division of Oncology and Hematology, Department of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Fleischhacker
Division of Oncology and Hematology, Department of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Ruhnke
Division of Oncology and Hematology, Department of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: markus.ruhnke@charite.de
DOI: 10.1128/AAC.01646-07
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article has a correction. Please see:

  • Secretion of E,E-Farnesol and Biofilm Formation in Eight Different Candida Species
    - January 22, 2009

ABSTRACT

Production of E,E-farnesol (FOH) and biofilm formation were studied under various conditions in 56 strains of eight Candida spp. FOH production differed significantly not only between Candida spp. but within Candida albicans strains as well. FOH concentrations and biofilm formation were the highest for C albicans.

Candida albicans is a major human fungal pathogen, causing both superficial and invasive tissue infections. The ability of C. albicans to form biofilms on medical devices has a profound impact on its capacity to cause human disease. C. albicans and other members of the genus Candida are able to grow in different forms as budding yeast, pseudohyphae, and true hyphae, which is called dimorphism (1, 8). This transition from yeast to hyphal growth can be induced by various conditions (2, 25). Progression to a mature biofilm is dependent on cell adhesion, extracellular matrix production, and the yeast-to-hypha transition in C. albicans (2, 3). However, biofilm development in non-C. albicans Candida spp. (NCAC) is not well understood.

Suppression of biofilm formation in C. albicans may be achieved by quorum-sensing molecules (5). E,E-Farnesol (FOH) has been reported to inhibit the induction of hyphal growth and biofilm formation in C. albicans (10, 11). In this study, FOH secretion by C. albicans and eight NCAC was examined under various culture conditions. In addition, the development of biofilms was studied. Finally, the correlation between FOH secretion and biofilm formation was analyzed for all of the isolates studied.

We studied 56 strains of eight Candida species (Table 1). All isolates were cultivated in RPMI 1640 medium with or without the addition of 10% fetal calf serum (FCS) at 37°C for 24 h under continuous rotation at 125 rpm. Two milliliters of sterile filtered (0.45 μm) culture supernatant was extracted with 5 ml n-hexane-ethanol (90:10, vol/vol) and derivatized with 9-anthroylnitrile as previously described (13). Quantification was done with n-butanol as an internal standard (50 ng added to each sample). Reverse-phase high-performance liquid chromatography was done with a YMC Hydrosphere C18 column (5 μm, 150 by 2.1 mm [inside diameter]). A linear gradient of acetonitrile-water (85% to 100% over 20 min) was used as the mobile phase. Standard concentrations ranged from 0.004 μM to 40 μM FOH. Detection, determination of recovery, and calculations were performed as previously described (4, 13). The development of biofilms by all of the Candida spp. was studied according to Krom et al. (6), with minor differences such as using 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt instead of 2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide. In addition to visual reading at 450 nm, optical density was measured at 405 nm for data validation (15). All tests were done twice and analyzed with the two-tailed paired Student t test comparing 0 and 10% FCS cultivations (significance was set at a P value of ≤0.05).

The quantification and standardization of FOH showed good linearity with R2 = 0.99. The recovery rate was determined as approximately 95%. The FOH concentrations for all 56 Candida strains are shown in Table 1. Under FCS-free conditions, the highest concentrations of FOH were measured for C. albicans isolates, with a mean of 35.6 μM (range, 13.7 to 58.5 μM). The quantity was up to 35 times higher than for NCAC, except for C. dubliniensis. The mean FOH concentration for C. dubliniensis was 8.3 μM (range, 6.0 to 17.5 μM). Individual C. albicans isolates varied remarkably in their ability to produce FOH. FOH concentrations were almost four times as high as for C. dubliniensis. All other NCAC showed relatively low concentrations of FOH (mean, 0.6 ± 0.2 μM), independently of whether the Candida strains were cultivated with or without supplementation with 10% FCS.

Significant decreases in the secretion of FOH were observed for C. albicans (P = 0.001), C. dubliniensis (P = 0.0007), and C. guilliermondii (P = 0.01) under FCS-supplemented culture conditions. The concentration of FOH for C. albicans decreased to 2.0 ± 0.9 μM (mean). The comparison of the FCS-free and 10% FCS cultivations indicated a significant disparity (P = 0.003).

The investigation of biofilm formation showed comparable results for both techniques (Fig. 1). An optical density cutoff of ≥0.2 (>35% transmission blocked) was used to discriminate biofilm producers according to recent suggestions (14, 15). With both media, C. albicans and C. dubliniensis formed good biofilms. C. dubliniensis isolates produced 48% more biofilm under FCS-free conditions than did C. albicans (no statistically significant difference). Addition of 10% FCS to the growth medium induced significantly better biofilm formation in five of the eight Candida species tested (Fig. 1; P < 0.05). With C. albicans, increased biofilm formation (by 76%) was observed with 10% FCS in the medium. Increased biofilm formation was also obtained for C. dubliniensis (34%), C. tropicalis (34%), and C. krusei (61%).

Quorum-sensing molecules, and FOH in particular, are considered to play an important role in the development of biofilms by C. albicans on the surfaces of medical devices (10-12). In this study, we found that C. dubliniensis can produce significant amounts of FOH but still less than C. albicans. In contrast, biofilm formation was more pronounced in C. dubliniensis than in any of the other Candida spp. tested. It is unclear whether this is related to the phylogenetic relationship between the two species or to other conditions (7). C. dubliniensis is a rare human pathogen and causes much less common invasive Candida infections in humans than do C. albicans and other NCAC. Furthermore, we have observed that several other NCAC do not produce any notable FOH but may form a biofilm (e.g., C. tropicalis, C. parapsilosis). The mechanism of reduced FOH production after supplementation with 10% FCS is unclear, but it is known that culture conditions may affect the global transcriptional response of Candida spp. (C. albicans) (9). It is assumed that the ability to form a biofilm is linked to FOH secretion as the major quorum-sensing molecule in C. albicans and C. dubliniensis, as shown in this study. We found that other Candida spp. can form biofilms without high levels of FOH, and it may be concluded that these NCAC use other pathways or quorum-sensing molecules for biofilm formation without FOH secretion.

Biofilm formation by NCAC is not well understood and requires further exploration with other models (e.g., gene regulation, detection of regulatory pathways).

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Biofilm formation by Candida species. Fifty-six Candida spp. were incubated for 24 h in RPMI 1640 medium containing 0% (A) or 10% (B) FCS. Biofilm formation was measured as described in the text. The average for all of the isolates of a species in Table 1 is shown as the result of 14 values calculated for each column. *, Significantly increased biofilm (P < 0.05) when cultured in medium with 10% FCS. WST-1, 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt.

View this table:
  • View inline
  • View popup
TABLE 1.

Candida spp. used in this study and concentrations of secreted FOH

FOOTNOTES

    • Received 21 December 2007.
    • Returned for modification 20 January 2008.
    • Accepted 2 March 2008.
  • ↵▿ Published ahead of print on 10 March 2008.

  • American Society for Microbiology

REFERENCES

  1. ↵
    Calderone, R. A. 2002. Taxonomy and biology of Candida, p. 15-28. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, DC.
  2. ↵
    Calderone, R. A., and W. A. Fonzi. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9:327-335.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Glowka, F. K., M. Karazniewicz, and E. Lipnicka. 2006. RP-HPLC method with fluorescence detection for determination of small quantities of triamcinolone in plasma in presence of endogenous steroids after derivatization with 9-anthroyl nitrile; pharmacokinetic studies. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 839:54-61.
    OpenUrlCrossRefPubMed
  5. ↵
    Hornby, J. M., and E. C. Jensen. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Krom, B. P., J. B. Cohen, G. E. Elhaney Feser, and R. L. Cihlar. 2007. Optimized candidal biofilm microtiter assay. J. Microbiol. Methods 68:421-423.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Mähnss, B., F. Stehr, W. Schafer, and K. Neuber. 2005. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis. Mycoses 48:55-61.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    Mitchell, A. P. 1998. Dimorphism and virulence in Candida albicans. Curr. Opin. Microbiol. 1:687-692.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Murillo, L. A., G. Newport, C. Y. Lan, S. Habelitz, J. Dungan, and N. M. Agabian. 2005. Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot. Cell 4:1562-1573.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Nickerson, K. W., A. L. Atkin, and J. M. Hornby. 2006. Quorum sensing in dimorphic fungi: farnesol and beyond. Appl. Environ. Microbiol. 72:3805-3813.
    OpenUrlFREE Full Text
  11. ↵
    Ramage, G., S. P. Saville, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Ramage, G., K. VandeWalle, B. L. Wickes, and J. L. López-Ribot. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:163-170.
    OpenUrlPubMed
  13. ↵
    Saisho, Y., A. Morimoto, and T. Umeda. 1997. Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal. Biochem. 252:89-95.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Shin, J. H., S. J. Kee, M. G. Shin, S. H. Kim, D. H. Shin, S. K. Lee, S. P. Suh, and D. W. Ryang. 2002. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J. Clin. Microbiol. 40:1244-1248.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Tumbarello, M., B. Posteraro, E. M. Trecarichi, B. Fiori, M. Rossi, R. Porta, K. de Gaetano Donati, M. La Sorda, T. Spanu, G. Fadda, R. Cauda, and M. Sanguinetti. 2007. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45:1843-1850.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Secretion of E,E-Farnesol and Biofilm Formation in Eight Different Candida Species
K. Weber, R. Sohr, B. Schulz, M. Fleischhacker, M. Ruhnke
Antimicrobial Agents and Chemotherapy Apr 2008, 52 (5) 1859-1861; DOI: 10.1128/AAC.01646-07

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Secretion of E,E-Farnesol and Biofilm Formation in Eight Different Candida Species
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
Share
Secretion of E,E-Farnesol and Biofilm Formation in Eight Different Candida Species
K. Weber, R. Sohr, B. Schulz, M. Fleischhacker, M. Ruhnke
Antimicrobial Agents and Chemotherapy Apr 2008, 52 (5) 1859-1861; DOI: 10.1128/AAC.01646-07
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596